Mimedx (MDXG) Total Liabilities (2010 - 2026)
Mimedx recorded quarterly Total Liabilities of $65.7 million in Q1 2026, down 23.65% quarter-over-quarter from $86.1 million in Q4 2025, and down 2.81% year-over-year from $67.6 million in Q1 2025.
Mimedx's Total Liabilities history runs 17 years deep, the most recent figure standing at $65.7 million for Q1 2026.
- In Q1 2026, Total Liabilities fell 2.81% year-over-year to $65.7 million; the TTM figure through Mar 2026 stood at $65.7 million (down 2.81% YoY), while the FY2025 annual figure was $86.1 million, up 21.6% from the prior year.
- Total Liabilities came in at $65.7 million for Q1 2026 at Mimedx, down from $86.1 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $99.8 million in Q3 2022 to a low of $62.1 million in Q2 2024.
- A 5-year average of $82.0 million and a median of $86.1 million in 2025 frame the typical range for Total Liabilities.
- Across the five-year window, Total Liabilities sank 35.64% in 2024 and gained 27.29% in 2025, its largest moves.
- Mimedx's Total Liabilities stood at $96.9 million in 2022, then slipped by 0.61% to $96.3 million in 2023, then decreased by 26.49% to $70.8 million in 2024, then increased by 21.6% to $86.1 million in 2025, then declined by 23.65% to $65.7 million in 2026.
- According to Business Quant data, Total Liabilities over the past three periods registered $65.7 million, $86.1 million, and $80.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 16.35 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1.74 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 731.60 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 177.22 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 19.51 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 7.12 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 10.44 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 9.45 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 4.05 Bn |
| 10 | Mimedx | 530.69 Mn | 370.92 Mn | 41.62 Mn | 65.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 65.74 Mn |
| Dec 31, 2025 | 86.11 Mn |
| Sep 30, 2025 | 80.04 Mn |
| Jun 30, 2025 | 74.49 Mn |
| Mar 31, 2025 | 67.64 Mn |
| Dec 31, 2024 | 70.81 Mn |
| Sep 30, 2024 | 62.88 Mn |
| Jun 30, 2024 | 62.14 Mn |
| Mar 31, 2024 | 65.95 Mn |
| Dec 31, 2023 | 96.33 Mn |
| Sep 30, 2023 | 95.20 Mn |
| Jun 30, 2023 | 96.55 Mn |
| Mar 31, 2023 | 93.61 Mn |
| Dec 31, 2022 | 96.92 Mn |
| Sep 30, 2022 | 99.82 Mn |
| Jun 30, 2022 | 89.78 Mn |
| Mar 31, 2022 | 89.38 Mn |
| Dec 31, 2021 | 95.35 Mn |
| Sep 30, 2021 | 93.84 Mn |
| Jun 30, 2021 | 101.79 Mn |
| Mar 31, 2021 | 106.83 Mn |
| Dec 31, 2020 | 110.61 Mn |
| Sep 30, 2020 | 109.35 Mn |
| Jun 30, 2020 | 128.05 Mn |
| Mar 31, 2020 | 128.57 Mn |
| Dec 31, 2019 | 132.77 Mn |
| Sep 30, 2019 | 139.69 Mn |
| Jun 30, 2019 | 145.63 Mn |
| Mar 31, 2019 | 69.09 Mn |
| Dec 31, 2018 | 73.19 Mn |
| Sep 30, 2018 | -84.71 Mn |
| Jun 30, 2018 | -81.15 Mn |
| Mar 31, 2018 | -75.26 Mn |
| Dec 31, 2017 | 47.46 Mn |
| Sep 30, 2017 | 36.24 Mn |
| Jun 30, 2017 | 52.60 Mn |
| Mar 31, 2017 | 59.46 Mn |
| Dec 31, 2016 | 69.21 Mn |
| Sep 30, 2016 | 58.39 Mn |
| Jun 30, 2016 | 55.45 Mn |
| Mar 31, 2016 | 62.98 Mn |
| Dec 31, 2015 | 27.93 Mn |
| Sep 30, 2015 | 25.41 Mn |
| Jun 30, 2015 | 20.60 Mn |
| Mar 31, 2015 | 19.70 Mn |
| Dec 31, 2014 | 19.93 Mn |
| Sep 30, 2014 | 16.06 Mn |
| Jun 30, 2014 | 11.54 Mn |
| Mar 31, 2014 | 11.11 Mn |
| Dec 31, 2013 | 11.13 Mn |
| Sep 30, 2013 | 9.76 Mn |
| Jun 30, 2013 | 7.39 Mn |
| Mar 31, 2013 | 6.26 Mn |
| Dec 31, 2012 | 15.18 Mn |
| Sep 30, 2012 | 14.35 Mn |
| Jun 30, 2012 | 11.80 Mn |
| Mar 31, 2012 | 14.36 Mn |
| Dec 31, 2011 | 15.20 Mn |
| Sep 30, 2011 | 11.70 Mn |
| Jun 30, 2011 | 11.36 Mn |
| Dec 31, 2010 | 1.25 Mn |